Our Mission

We build platforms
for global health

Our Mission

We build platforms
for immunotherapies and vaccines

Our Mission

We build platforms
for those who need them most


AAHI to Present at The 10th International mRNA Health Conference November 8th

The Turnaround Management Association Recognizes the Transition from the Infectious Disease Research Institute to the Access to Advanced Health Institute as the Most Successful Turnaround and Restructuring of the Year!

AAHI adjuvant formulation profiles included in the National Institute of Health’s Vaccine Adjuvant Compendium. Adjuvant formulations are not a one-size fits all solution to enhancing immune responses. Find out which adjuvant formulation may be most suited to your purpose.

We Discover

AAHI leverages its RNA and adjuvant formulations expertise to pioneer the development of platforms for next generation vaccines and immunotherapies.

We Develop

Our in-house manufacturing, formulation, and product development services enable development of powerful prophylactic and therapeutic solutions to address real-world needs.

We Deploy

Our platform technology facilitates rapid vaccine and immunotherapy development and distribution, to make life-enhancing products equitably accessible around the world.

Our Formulations

Next Generation Solutions

Our expertise in RNA vaccines and adjuvant formulations has set the stage for revolutionary development and improvement of potent, broad, and durable vaccines that are commercially scalable and accessible across diverse geographic, cultural, and economic regions.

About Us

Who Is AAHI?

AAHI is focused on solving fundamental scientific challenges that impede the ability of the biomedical community to deliver on our shared goal – protecting and improving people’s health around the world.

AAHI Is All About Collaboration.

Our commitment to global equity permeates our efforts to forge collaborations and partnerships to make immunologic innovations equitably accessible to the people who most need them.